DESMOPRESSIN vs DEUCRAVACITINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
DESMOPRESSIN vs DEUCRAVACITINIB: Safety Overview
| Metric | DESMOPRESSIN | DEUCRAVACITINIB |
|---|---|---|
| Total FAERS Reports | 3,903 | 2,386 |
| Deaths Reported | 170 | 36 |
| Death Rate | 4.4% | 1.5% |
| Hospitalizations | 1,314 | 121 |
| Average Patient Age | 46.6 yrs | 56.8 yrs |
| % Female Patients | 51.7% | 63.8% |
| FDA Approval Date | Approved Prior to Jan 1, 1982 | Sep 9, 2022 |
| Manufacturer | Gland Pharma Limited | E.R. Squibb & Sons, L.L.C. |
| Route | INTRAVENOUS | ORAL |
| Marketing Status | Discontinued | Prescription |